TrialGynecologic oncology2013

Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer.

Israel Zighelboim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.